MARK SCHOENEBAUM, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

TG THERAPEUTICS, INC.

Filing Date Source Excerpt
2012-03-15 Mark Schoenebaum, M.D., 39, was nominated to our Board in March 2012. ... The following individuals are being nominated to serve on our Board (See “Proposal 1 – Election of Directors; Nominees”): ... Mark Schoenebaum, M.D. 39 Director-Nominee 2012
2013-04-24 Mark Schoenebaum, M.D., 40, was nominated to our Board in March 2012. ... The Audit Committee currently consists of Laurence N. Charney, William Kennedy and Neil Herskowitz. ... 2012 Director Compensation: Mark Schoenebaum, M.D. Fees Earned or Paid in Cash $17,720 Stock Awards $310,000 Total $327,720.
2014-04-23 Mark Schoenebaum, M.D., 41, was nominated to our Board in March 2012. 2013 Director Compensation: Mark Schoenebaum, M.D. Fees Earned or Paid in Cash ($) 25,000 Stock Awards ($) 104,178 Total ($) 129,178
2015-04-24 Mark Schoenebaum, M.D., 42, has served on our Board since April 2012. The following table sets forth the cash and other compensation paid by the Company to the non-employee members of the Board for all services in all capacities during 2014. Mark Schoenebaum, M.D. 37,500 cash, 74,997 stock awards, total 112,497.
2016-04-29 Mark Schoenebaum, M.D., 43, has served on our Board since April 2012. Dr. Schoenebaum is a Senior Managing Director, Head of Evercore ISI's Health Care Research Team. The Compensation Committee currently consists of all independent members of our Board of Directors, with Mr. Hoberman as chairman. Our non-employee directors receive the following cash compensation: (i) $50,000 annual retainer; and (ii) $10,000 additional retainer for service as Chairman of the Audit Committee.
2017-04-28 The Compensation Committee currently consists of all independent members of our Board of Directors, with Mr. Hoberman as chairman. The following table sets forth the cash and other compensation paid by the Company to the non-employee members of the Board for all services in all capacities during 2016. Mark Schoenebaum, M.D.: Fees Earned or Paid in Cash $50,000, Stock Awards $75,003, Total $125,003.
2019-04-30 Mark Schoenebaum, M.D., 46, has served on our Board since April 2012. ... The Compensation Committee currently consists of all independent members of our Board of Directors, with Mr. Hoberman as chairman. ... The following table sets forth the cash and other compensation paid by the Company to the members of the Board for all services in all capacities during 2018.

Data sourced from SEC filings. Last updated: 2026-02-03